Holen Sie sich die Stockscreener-App
1.16
0.87%
0.01
Handel nachbörslich:
1.14
-0.02
-1.72%
Finanzdaten der Immunic Inc-Aktie (IMUX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.26%
23.33
|
25.99 | 27.08 | 26.82 | 25.63 |
| Provision For Loan, Lease, And Other Losses |
610.42%
0.341
|
0.048 | 0.055 | 0.053 | - |
| Depreciation and Amortization |
5.00%
0.042
|
0.04 | 0.043 | 0.043 | - |
| Operating Income/Loss |
10.26%
-23.33
|
-25.99 | -27.08 | -26.82 | -25.63 |
| Nonoperating Income/Loss |
872.71%
4.027
|
0.414 | 0.263 | 1.352 | 0.456 |
| Income/Loss From Continuing Operations Before Tax |
24.55%
-19.30
|
-25.58 | -26.82 | -25.47 | -25.18 |
| Income/Loss From Continuing Operations After Tax |
24.55%
-19.30
|
-25.58 | -26.82 | -25.47 | -25.18 |
|
Net Income/Loss
|
24.55%
-19.30
|
-25.58 | -26.82 | -25.47 | -25.18 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
93.36%
12.88
|
193.90 | 132.18 | 101.34 | 0.1765 |
| Diluted Average Shares |
93.36%
12.88
|
193.90 | 132.18 | 101.34 | 0.1765 |
| Basic Earnings Per Share |
46.15%
-0.07
|
-0.13 | -0.20 | -0.25 | -0.25 |
| Diluted Earnings Per Share |
46.15%
-0.07
|
-0.13 | -0.20 | -0.25 | -0.25 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.49%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):